1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with 3,4-dihydroxyphenylglycol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goldstein, DS; Johannessen, JN; Markey, SP; Oliver, J | 1 |
Bey, P; McDonald, IA; Palfreyman, MG; Schechter, PJ; Sjoerdsma, A | 1 |
Imanishi, M; Kaneda, K; Kita, H; Nambu, A; Shigemoto, R; Tachibana, Y; Takada, M | 1 |
3 other study(ies) available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 3,4-dihydroxyphenylglycol
Article | Year |
---|---|
Prolonged changes in plasma concentrations of catecholamine metabolites following a single infusion of an MPTP analog.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Adrenal Glands; Animals; Catecholamines; Dogs; Female; Injections, Intravenous; Male; Methoxyhydroxyphenylglycol; Normetanephrine; Sympathetic Nervous System; Time Factors | 1990 |
Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Allyl Compounds; Allylamine; Amines; Animals; Blood Platelets; Blood Pressure; Brain; Butylamines; Carbidopa; Dogs; Female; Heart Rate; Humans; In Vitro Techniques; Isoenzymes; Male; Methoxyhydroxyphenylglycol; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Pyridines; Rats; Rats, Inbred Strains; Serotonin; Tyramine | 1988 |
Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Behavior, Animal; Benzoates; Cell Count; Disease Models, Animal; Down-Regulation; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Glycine; Immunohistochemistry; Indans; Macaca fascicularis; Male; Methoxyhydroxyphenylglycol; Parkinsonian Disorders; Receptors, Metabotropic Glutamate; Severity of Illness Index; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |